3bg4: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor== | ==The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor== | ||
<StructureSection load='3bg4' size='340' side='right' caption='[[3bg4]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='3bg4' size='340' side='right'caption='[[3bg4]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3bg4]] is a 4 chain structure with sequence from [ | <table><tr><td colspan='2'>[[3bg4]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus] and [https://en.wikipedia.org/wiki/Hirudo_nipponia Hirudo nipponia]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3BG4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3BG4 FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3bg4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3bg4 OCA], [https://pdbe.org/3bg4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3bg4 RCSB], [https://www.ebi.ac.uk/pdbsum/3bg4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3bg4 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/GUAM_HIRNI GUAM_HIRNI] Inhibits mammalian elastases. | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/bg/3bg4_consurf.spt"</scriptWhenChecked> | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/bg/3bg4_consurf.spt"</scriptWhenChecked> | ||
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/ | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
</jmolCheckbox> | </jmolCheckbox> | ||
| Line 30: | Line 30: | ||
==See Also== | ==See Also== | ||
*[[Chymotrypsin|Chymotrypsin]] | *[[Chymotrypsin 3D structures|Chymotrypsin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 36: | Line 36: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Bos taurus]] | [[Category: Bos taurus]] | ||
[[Category: | [[Category: Hirudo nipponia]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Choi | [[Category: Choi J]] | ||
[[Category: Chu | [[Category: Chu TTT]] | ||
[[Category: Hahn | [[Category: Hahn MJ]] | ||
[[Category: Kim | [[Category: Kim DR]] | ||
[[Category: Kim | [[Category: Kim DY]] | ||
[[Category: Kim | [[Category: Kim H]] | ||
[[Category: Kim | [[Category: Kim KK]] | ||
[[Category: Lee | [[Category: Lee JR]] | ||
[[Category: Nguyen | [[Category: Nguyen CMT]] | ||
Latest revision as of 10:53, 9 October 2024
The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitorThe crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor
Structural highlights
FunctionGUAM_HIRNI Inhibits mammalian elastases. Evolutionary Conservation Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedGuamerin, a canonical serine protease inhibitor from Hirudo nipponia, was identified as an elastase-specific inhibitor and has potential application in various diseases caused by elevated elastase concentration. However, the application of guamerin is limited because it also shows inhibitory activity against other proteases. To improve the selectivity of guamerin as an elastase inhibitor, it is essential to understand the binding mode of the inhibitor to elastase and to other proteases. For this purpose, we determined the crystal structure of guamerin in complex with chymotrypsin at 2.5 A resolution. The binding mode of guamerin on elastase was explored from the model structure of guamerin/elastase. Guamerin binds to the hydrophobic pocket of the protease in a substrate-like manner using its binding loop. In order to improve the binding selectivity of guamerin to elastase, several residues in the binding loop were mutated and the inhibitory activities of the mutants against elastase and chymotrypsin were monitored. The substitution of the Met36 residue for Ala in the P1 site increased the inhibitory activity against elastase up to 14-fold, while the same mutant showed 7-fold decreased activity against chymotrypsin compared to the wild-type guamerin. Furthermore, the M36A guamerin mutant more effectively protected endothelial cells against cell damage caused by elastase than the wild-type guamerin. The crystal structure of guamerin in complex with chymotrypsin and the development of an elastase-specific inhibitor.,Kim H, Chu TT, Kim DY, Kim DR, Nguyen CM, Choi J, Lee JR, Hahn MJ, Kim KK J Mol Biol. 2008 Feb 8;376(1):184-92. Epub 2007 Dec 4. PMID:18155725[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||